NCT05444270
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Yonsei University Health System, Severance Hospital Seoul, South Korea
Clinical trial condition
Recurrent Epithelial Ovarian Cancer
Explore clinical trials studying Recurrent Epithelial Ovarian Cancer. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Recurrent Epithelial Ovarian Cancer trial results
NCT05700669
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +23 more
- Locations
-
- Next Oncology San Antonio, Texas, United States
Completed
Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT01853644
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- CDH-Delnor Health System - Northwestern Medicine Cancer Center Warrenville, Illinois, United States
NCT01815528
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Charité Campus Virchow-Klinikum Berlin, Germany
Active, Not Recruiting
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
NCT05335993
- Conditions
- Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more
- Locations
-
- Duke Cancer Center Durham, North Carolina, United States
- Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
- University of Virginia Health System Charlottesville, Virginia, United States